1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with fibrinogen in 51 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (fibrinogen) | Trials (fibrinogen) | Recent Studies (post-2010) (fibrinogen) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 34,477 | 1,707 | 7,083 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (27.45) | 18.7374 |
1990's | 28 (54.90) | 18.2507 |
2000's | 8 (15.69) | 29.6817 |
2010's | 1 (1.96) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akkerman, JW; van Willigen, G | 2 |
Cattaneo, M; Lecchi, A; Mannucci, PM; McGregor, JL; Randi, AM | 1 |
Akkerman, JW; Burgers, JA | 1 |
Feuerstein, G; Lynch, KM; Ohlstein, EH; Poyser, R; Rabinovici, R; Sellers, TS; Slivjak, MJ; Smith, EF; Sulpizio, A; Yue, TL | 1 |
Butler, KD; Crook, P; May, GR; Page, CP; Paul, W | 1 |
Javors, MA; Olson, MS; Zhou, W | 1 |
Ekholm, J; Hanahan, DJ; Nouchi, T; Tatsumi, Y | 1 |
Goldie, RG; Pedersen, KE; Rigby, PJ | 1 |
Lorant, DE; McEver, RP; McIntyre, TM; Patel, KD; Prescott, SM; Zimmerman, GA | 1 |
Imanishi, N; Komuro, Y; Morooka, S | 1 |
Baba, I; Hayashi, Y; Katagiri, Y; Suzuki, H; Tanoue, K; Yamazaki, H | 1 |
Crane, S; Johnstone, IB; Viel, L; Whiting, T | 1 |
Kosugi, T; Minei, S; Nakamura, M; Noguchi, S; Saitoh, S; Shimoji, T | 1 |
Apitz-Castro, R; Bartoli, F; Jain, MK; Ledezma, E; Ruiz, MC; Salas, R | 1 |
Hayasaki, Y; Honma, Y; Kakushi, H; Kawasumi, K; Matsubara, T; Shike, T; Takeuchi, Y; Uchida, K | 1 |
Budzynski, A; Scrutton, MC; Shattil, SJ | 1 |
Herd, C; Morley, J; Sanjar, S; Smith, D | 1 |
Carreras, LO; Kaminker, AJ | 1 |
Firkin, BG; Sloan, IG | 1 |
Akkerman, JW; Kloprogge, E; Mommersteeg, M | 1 |
Hatzfeld, A; Hatzfeld, J; Levesque, JP | 1 |
Akkerman, JW; Gorter, G; Hasselaar, P; Kloprogge, E | 1 |
Akkerman, JW; Kloprogge, E | 2 |
Des Prez, RM; Gates, C; King, LE; Rees, RS; Timmons, S | 1 |
Akkerman, JW; Hasselaar, P; Kloprogge, E | 1 |
Ma, YH; Ouyang, CH; Teng, CM | 1 |
Benveniste, J; Bidault, J; Morley, J; Page, C; Pirotzky, E | 1 |
Akkerman, JW; de Haas, GH; Gorter, G; Kloprogge, E | 1 |
Burns, AR; Gopalan, PK; Lynam, EB; Simon, SI; Sklar, LA; Smith, CW; Taylor, AD | 1 |
Chern, JW; Chou, TC; Ding, YA; Yen, MH | 1 |
Burstein, SA; Dale, GL; George, JN; Heilmann, E; Hynes, LA | 1 |
Kambayashi, J; Kawasaki, T; Mori, T; Ou, MC; Sakon, M; Shiba, E; Shinozaki, K; Uemura, Y; Yukawa, M | 1 |
Bull, DA; Hendrix, MJ; Hunter, GC; Larson, DF; Putnam, CW; Seftor, EA | 1 |
Iwamoto, N; Kambayashi, J; Kawasaki, T; Mori, T; Ou, M; Sakon, M; Shiba, E; Shinozaki, K; Uemura, Y | 1 |
Gabbeta, J; McLane, MA; Niewiarowski, S; Rao, AK; Sun, L; Yang, X | 1 |
Akkerman, JW; Gorter, G; Hers, I; van Willigen, G | 1 |
Bailie, MB; Fink, GD; Pearson, JM; Roth, RA | 1 |
Evanson, OA; Weiss, DJ | 1 |
Springer, TA; Weber, C | 1 |
Le Blanc, K; Lindahl, T; Rosendahl, K; Samuelsson, J | 1 |
Aiboshi, J; Ciesla, DJ; Moore, EE; Silliman, CC | 1 |
Arias-Salgado, EG; Ayuso, MS; Butta, N; González-Manchón, C; Larrucea, S; Parrilla, R; Shen, L | 1 |
Bayly, WM; Kingston, JK; Meyers, KM; Sellon, DC; Wardrop, KJ | 1 |
Elisaf, M; Milionis, HJ; Mitsios, JV; Tselepis, AD; Tsironis, LD | 1 |
Geng, JG; Ma, YQ; Plow, EF | 1 |
Antonopoulou, S; Athanasopoulos, S; Fragopoulou, E; Milias, GA; Nomikos, T | 1 |
Antunes, E; Fonseca, FV; Marangoni, S; Martins, AM; Monteiro, HS; Morganti, RP; Toyama, DO; Toyama, MH | 1 |
Day, JR; Ghimire, G; Leong, HS; Mahesh, BM; McCormack, AD; Podor, TJ; Rose, ML; Smith, JD | 1 |
Fang, L; Liu, J; Tan, B; Zhang, P; Zhu, F | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and fibrinogen
Article | Year |
---|---|
[Physiopathology of thrombotic microangiopathy].
Topics: Blood Coagulation Factors; Blood Platelets; Cell Survival; Endothelium, Vascular; Epoprostenol; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Platelet Activating Factor; Purpura, Thrombotic Thrombocytopenic | 1989 |
50 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and fibrinogen
Article | Year |
---|---|
Regulation of glycoprotein IIB/IIIA exposure on platelets stimulated with alpha-thrombin.
Topics: Alkaloids; Binding Sites; Blood Platelets; Bucladesine; Epoprostenol; Fibrinogen; Fibronectins; Hirudins; Humans; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Kinase C; Staurosporine; Thrombin | 1992 |
Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Blood Platelets; Calcium; Clot Retraction; Collagen; Cyclic AMP; Epinephrine; Fibrinogen; Hemorrhage; Humans; Indomethacin; Kinetics; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Prostaglandin Endoperoxides, Synthetic; Reference Values; Thrombin; Vasoconstrictor Agents; von Willebrand Factor | 1992 |
Effect of platelet agonists on the binding of platelet-activating factor to human platelets.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Blood Platelets; Fibrinogen; Humans; Iodine Radioisotopes; Platelet Activating Factor; Platelet Activation; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thrombin | 1992 |
Pharmacological profile of G619, a new platelet aggregation inhibitor.
Topics: Adenosine Diphosphate; Animals; Benzamides; Calcium; Collagen; Dogs; Epinephrine; Fibrinogen; Humans; Male; Phenylacetates; Picolines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Prostaglandin Endoperoxides, Synthetic; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Shock, Septic; Sulfonamides; Thrombin; Thromboxane B2; Vasoconstriction | 1992 |
The pharmacological modulation of thrombin-induced cerebral thromboembolism in the rabbit.
Topics: Animals; Anistreplase; Arginine; Blood Platelets; Diterpenes; Female; Fibrinogen; Fibrinolytic Agents; Ginkgolides; Hirudins; Injections, Intra-Arterial; Injections, Intravenous; Intracranial Embolism and Thrombosis; Lactones; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Polydeoxyribonucleotides; Rabbits; Recombinant Proteins; Thrombin | 1992 |
Platelet-activating factor as an intercellular signal in neutrophil-dependent platelet activation.
Topics: Amino Acid Sequence; Animals; Azepines; Blood Platelets; Cells, Cultured; Fibrinogen; Molecular Sequence Data; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoproteins; Rabbits; Signal Transduction; Thromboxane A2; Triazoles | 1992 |
The human platelet as a reproducible and sensitive cell for the detection and assay of platelet-activating factor.
Topics: Adenosine; Adenosine Diphosphate; Adult; Biological Assay; Blood Platelets; Citric Acid; Female; Fibrinogen; Glucose; Humans; In Vitro Techniques; Male; Platelet Activating Factor; Platelet Aggregation; Reproducibility of Results; Serotonin | 1992 |
Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin.
Topics: Animals; Autoradiography; Azepines; Bradykinin; Capillary Permeability; Fibrinogen; Guinea Pigs; Iodine Radioisotopes; Lung; Male; Paraffin Embedding; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pulmonary Circulation; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Trachea; Triazoles | 1991 |
Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils.
Topics: Antibodies, Monoclonal; Antigens, CD; CD11 Antigens; CD18 Antigens; Cell Adhesion; Cell Adhesion Molecules; Endothelium, Vascular; Fibrinogen; Histamine; Humans; In Vitro Techniques; Neutrophils; P-Selectin; Platelet Activating Factor; Platelet Membrane Glycoproteins; Thrombin; Up-Regulation | 1991 |
Effect of a selective PAF antagonist SM-10661 ((+/-)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC).
Topics: Administration, Oral; Animals; Disseminated Intravascular Coagulation; Endotoxins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gabexate; Infusions, Intravenous; Injections, Intraperitoneal; Partial Thromboplastin Time; Platelet Activating Factor; Platelet Count; Prothrombin Time; Rats; Thiazoles; Thiazolidines | 1991 |
Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets.
Topics: Adenosine Diphosphate; Binding Sites; Blood Platelets; Cyclic AMP; Epinephrine; Fibrinogen; Humans; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Kinase C; Signal Transduction; Temperature | 1991 |
Characterization of platelet aggregation induced by the human melanoma cell line HMV-I: roles of heparin, plasma adhesive proteins, and tumor cell membrane proteins.
Topics: Antibodies, Monoclonal; Azepines; Blood Coagulation Factors; Calcium; Cells, Cultured; Citrates; Citric Acid; Fibrinogen; Flow Cytometry; Heparin; In Vitro Techniques; Magnesium; Melanoma; Membrane Proteins; Microbial Collagenase; Neuraminidase; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Thrombospondins; Triazoles; Trypsin | 1991 |
Hemostatic studies in racing standardbred horses with exercise-induced pulmonary hemorrhage. Hemostatic parameters at rest and after moderate exercise.
Topics: Adenosine Diphosphate; Animals; Antithrombin III; Collagen; Factor VIII; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemorrhage; Hemostasis; Horse Diseases; Horses; Lung Diseases; Partial Thromboplastin Time; Physical Exertion; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Prothrombin Time; Thrombin Time; von Willebrand Factor | 1991 |
Changes in parameters of the coagulation-fibrinolysis system and platelet function after OKY-046 administration to patients with ruptured aneurysm of the cerebral artery.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Blood Coagulation; Blood Platelets; Collagen; Female; Fibrinogen; Fibrinolysis; Humans; Intracranial Aneurysm; Male; Methacrylates; Middle Aged; Plasminogen Inactivators; Platelet Activating Factor; Rupture, Spontaneous; Thromboxane-A Synthase; Tissue Plasminogen Activator | 1991 |
Evidence for direct coupling of primary agonist-receptor interaction to the exposure of functional IIb-IIIa complexes in human blood platelets. Results from studies with the antiplatelet compound ajoene.
Topics: Antibodies, Monoclonal; Blood Platelets; Calcium; Chymotrypsin; Collagen; Cytoplasm; Disulfides; Enzyme Activation; Epinephrine; Fibrinogen; GTP-Binding Proteins; Humans; Phosphorylation; Plant Extracts; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Kinase C; Sodium Fluoride; Sulfoxides; Thrombin | 1991 |
[Effect of cefaclor on guinea pig platelet aggregation in vitro].
Topics: Adenosine Diphosphate; Animals; Calcium; Cefaclor; Cephalexin; Fibrinogen; Guinea Pigs; In Vitro Techniques; Male; Membrane Glycoproteins; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin | 1990 |
Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists.
Topics: Adenosine Diphosphate; Antibodies, Monoclonal; Blood Platelets; Epinephrine; Fibrinogen; Flow Cytometry; Humans; Platelet Activating Factor; Platelet Aggregation; Receptors, Cell Surface; Receptors, Peptide; Serotonin; Thrombin | 1989 |
In vivo method for the assessment of platelet accumulation.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Collagen; Drug Evaluation, Preclinical; Erythrocytes; Fibrinogen; Guinea Pigs; Indium Radioisotopes; Male; Microcomputers; Monitoring, Physiologic; Platelet Activating Factor; Platelet Aggregation; Radioisotope Dilution Technique | 1989 |
Impaired fibrinolysis in patients with thrombotic or haemostatic defects.
Topics: Adolescent; Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Child; Child, Preschool; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Plasminogen Inactivators; Platelet Activating Factor; Platelet Function Tests; Retrospective Studies; Thrombosis | 1989 |
Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced fibrinogen binding to human platelets.
Topics: Binding Sites; Blood Platelets; Fibrinogen; Humans; Kinetics; Mathematics; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Time Factors | 1986 |
Fibrinogen mitogenic effect on hemopoietic cell lines: control via receptor modulation.
Topics: Adenosine Diphosphate; Binding Sites; Binding, Competitive; Blood Platelets; Bucladesine; Cell Line; Edetic Acid; Fibrinogen; Hematopoietic Stem Cells; Humans; Mitogens; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Thrombin | 1986 |
Stimulus-aggregation coupling in platelets activated with PAF-acether.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcium; Cytosol; Fibrinogen; Humans; Kinetics; Molecular Weight; Phosphatidylinositols; Phosphoproteins; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Temperature; Thromboxane B2 | 1986 |
Platelet-activating factor (PAF-acether) induces high- and low-affinity binding of fibrinogen to human platelets via independent mechanisms.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Fibrinogen; Humans; Indomethacin; Kinetics; Macromolecular Substances; Platelet Activating Factor; Prostaglandin Endoperoxides; Protein Binding; Thromboxanes | 1986 |
Plasma components are required for platelet activation by the toxin of Loxosceles reclusa.
Topics: Adenosine Diphosphate; Arthropod Venoms; Blood Platelets; Calcium; Fibrinogen; Humans; In Vitro Techniques; Plasma; Platelet Activating Factor; Platelet Aggregation; Prostaglandins; Serotonin; Spider Venoms | 1988 |
PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy.
Topics: Blood Platelets; Cyanides; Deoxyglucose; Energy Metabolism; Fibrinogen; Humans; Platelet Activating Factor; Platelet Aggregation; Protein Binding; Stimulation, Chemical | 1986 |
Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom.
Topics: Adenosine Diphosphate; Alprostadil; Animals; Arachidonic Acid; Arachidonic Acids; Calcimycin; Chymotrypsin; Collagen; Fibrinogen; Heparin; Hirudins; Platelet Activating Factor; Platelet Aggregation; Prostaglandins E; Rabbits; Thrombin; Viper Venoms | 1985 |
Vascular permeability induced by Paf-acether (platelet-activating factor) in the isolated perfused rat kidney.
Topics: Animals; Capillary Permeability; Fibrinogen; In Vitro Techniques; Kidney; Male; Perfusion; Platelet Activating Factor; Rats; Rats, Inbred Strains; Renal Circulation | 1985 |
Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets.
Topics: Adrenergic alpha-Antagonists; Binding Sites; Blood Platelets; Calcium; Chromatography, Gel; Fibrinogen; Humans; Kinetics; Phosphatidylinositols; Platelet Activating Factor; Platelet Aggregation; Protein Binding | 1984 |
Properties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered human platelets.
Topics: Acetylglucosaminidase; Animals; beta-Thromboglobulin; Blood Platelets; Calcium; Chromatography, Gel; Fibrinogen; Humans; Magnesium; Platelet Activating Factor; Platelet Aggregation; Rabbits; Serotonin | 1983 |
L-selectin (CD62L) cross-linking signals neutrophil adhesive functions via the Mac-1 (CD11b/CD18) beta 2-integrin.
Topics: Adult; Antibodies, Monoclonal; CD18 Antigens; Cell Adhesion; Cell Adhesion Molecules; Chemotaxis, Leukocyte; Collagen; Endothelium, Vascular; Fibrinogen; Flow Cytometry; Humans; Immunoglobulin Fab Fragments; Integrins; L-Selectin; Macrophage-1 Antigen; Microspheres; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Protein Conformation; Receptor Aggregation; Serum Albumin; Signal Transduction | 1995 |
Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Arachidonic Acid; Blood Platelets; Calcium; Collagen; Cyclic AMP; Epinephrine; Fibrinogen; Humans; Imidazoles; Pancreatic Elastase; Phosphatidylinositols; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Quinazolines; Rabbits; Receptors, Cell Surface; Signal Transduction; Thromboxane A2; Thromboxane B2 | 1995 |
Fluorescein derivatization of fibrinogen for flow cytometric analysis of fibrinogen binding to platelets.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Cellular Senescence; Dogs; Edetic Acid; Fibrinogen; Flow Cytometry; Fluoresceins; Humans; Platelet Activating Factor; Platelet Activation | 1994 |
Potential etiologic role of PAF in two major septic complications; disseminated intravascular coagulation and multiple organ failure.
Topics: Alanine Transaminase; Animals; Bacterial Infections; Blood Cell Count; Blood Urea Nitrogen; Cholangitis; Common Bile Duct; Disseminated Intravascular Coagulation; Endotoxins; Fibrinogen; Hematocrit; Liver; Male; Multiple Organ Failure; Partial Thromboplastin Time; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Rabbits | 1994 |
Putative vascular endothelial cell chemotactic factors: comparison in a standardized migration assay.
Topics: Adenosine; Animals; Cattle; Cells, Cultured; Chemotactic Factors; Chemotaxis; Endothelium, Vascular; Epidermal Growth Factor; Fibrinogen; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Magnesium Sulfate; Platelet Activating Factor; Platelet-Derived Growth Factor; Pulmonary Artery; Transforming Growth Factor alpha | 1993 |
A new method of purification and sensitive bioassay of platelet-activating factor (PAF) in human whole blood.
Topics: Animals; Biological Assay; Epinephrine; Fibrinogen; Humans; Infections; Liver Cirrhosis; Platelet Activating Factor; Platelet Aggregation; Rabbits; Radioimmunoassay; Sensitivity and Specificity | 1994 |
Abnormal inside-out signal transduction-dependent activation of glycoprotein IIb-IIIa in a patient with impaired pleckstrin phosphorylation.
Topics: Adenine Nucleotides; Adolescent; Antibodies, Monoclonal; Blood Proteins; Fibrinogen; Flow Cytometry; Humans; Male; Phosphoproteins; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase C; Serotonin; Signal Transduction; Thrombin; Thromboxane A2 | 1996 |
Exposure of ligand-binding sites on platelet integrin alpha IIB/beta 3 by phosphorylation of the beta 3 subunit.
Topics: Alkaloids; Benzoquinones; Binding Sites; Blood Platelets; Enzyme Inhibitors; Fibrinogen; Fibronectins; Humans; In Vitro Techniques; Indoles; Kinetics; Lactams, Macrocyclic; Ligands; Maleimides; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase C; Protein Kinase Inhibitors; Protein Kinases; Protein-Tyrosine Kinases; Quinones; Rifabutin; Staurosporine | 1996 |
Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration.
Topics: Administration, Oral; Alanine Transaminase; Animals; Azepines; Blood Platelets; Chemical and Drug Induced Liver Injury; Female; Fibrinogen; Hydroxyurea; Injections, Intraperitoneal; Injections, Intravenous; Leukotrienes; Lipopolysaccharides; Lipoxygenase Inhibitors; Liver; Liver Diseases; Necrosis; Neutrophils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thrombocytopenia; Triazoles | 1997 |
Detection of activated platelets and platelet-leukocyte aggregates in horses.
Topics: Adenosine Diphosphate; Analysis of Variance; Animals; Blood Platelets; Cell Aggregation; Erythrocytes; Fibrinogen; Flow Cytometry; Horses; Humans; Leukocytes; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombin | 1997 |
Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor.
Topics: Antigens, CD; Blood Platelets; Calcium; Cell Adhesion; Cell Adhesion Molecules; Fibrinogen; Humans; Integrins; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen; Magnesium; Movement; Neutrophils; Platelet Activating Factor; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombasthenia | 1997 |
Impaired platelet binding of fibrinogen due to a lower number of GPIIB/IIIA receptors in polycythemia vera.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD; Blood Platelets; Female; Fibrinogen; Flow Cytometry; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Polycythemia Vera; Serotonin; Tetradecanoylphorbol Acetate | 1998 |
Blood transfusion and the two-insult model of post-injury multiple organ failure.
Topics: Blood Preservation; Cell Adhesion; Cells, Cultured; Chemotaxis, Leukocyte; Drug Synergism; Endothelium, Vascular; Fibrinogen; Humans; Inflammation; Lysophosphatidylcholines; Models, Biological; Multiple Organ Failure; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxidative Stress; Platelet Activating Factor; Risk; Superoxides; Transfusion Reaction | 2001 |
Agonist-induced aggregation of Chinese hamster ovary cells coexpressing the human receptors for fibrinogen (integrin alphaIIbbeta3) and the platelet-activating factor: dissociation between adhesion and aggregation.
Topics: Animals; Cell Adhesion; Cell Aggregation; CHO Cells; Cricetinae; Fibrinogen; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Activating Factor; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Signal Transduction; Transfection | 2002 |
Measurement of the activation of equine platelets by use of fluorescent-labeled annexin V, anti-human fibrinogen antibody, and anti-human thrombospondin antibody.
Topics: Animals; Annexin A5; Antibodies; Blood Platelets; Calcimycin; Fibrinogen; Flow Cytometry; Fluorescent Dyes; Horses; Ionophores; Platelet Activating Factor; Platelet Activation; Thrombospondins | 2002 |
Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Blood Platelets; Depression, Chemical; Fibrinogen; Humans; In Vitro Techniques; Lipoprotein(a); Platelet Activating Factor; Platelet Activation | 2004 |
P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alphaMbeta2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils.
Topics: Antibodies; Cell Adhesion; Fibrinogen; Humans; Interleukin-8; Macrophage-1 Antigen; Membrane Glycoproteins; Neutrophils; P-Selectin; Platelet Activating Factor; Solubility; Up-Regulation | 2004 |
Effects of eccentric exercise-induced muscle injury on blood levels of platelet activating factor (PAF) and other inflammatory markers.
Topics: Adult; C-Reactive Protein; Complement C3; Creatine Kinase; Elbow Joint; Exercise; Fibrinogen; Humans; Inflammation; L-Lactate Dehydrogenase; Leukocyte Count; Male; Muscle Contraction; Muscle, Skeletal; Platelet Activating Factor; Torque | 2005 |
Characterization of a new platelet aggregating factor from crotoxin Crotalus durissus cascavella venom.
Topics: Amino Acid Sequence; Animals; Blood Platelets; Crotalid Venoms; Crotalus; Crotoxin; Fibrinogen; Molecular Sequence Data; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation; Serine Endopeptidases; Serine Proteinase Inhibitors; Thrombin; Tosyllysine Chloromethyl Ketone | 2006 |
Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor.
Topics: Apoptosis; Autoantibodies; Autoimmune Diseases; Blood Platelets; Cell Adhesion; Complement C3d; Culture Media, Conditioned; Fibrinogen; Humans; Immunoglobulin M; Immunosorbent Techniques; Leukocytes; P-Selectin; Platelet Activating Factor; Platelet Activation; Pyridinium Compounds; Recombinant Proteins; Thrombophilia; Thromboplastin; Vimentin | 2008 |
[Hypercoagulable state is associated with NF-kappa B activation and increased inflammatory factors in patients with rheumatoid arthritis].
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Blood Coagulation; Blood Coagulation Tests; Blotting, Western; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Inflammation Mediators; Male; Middle Aged; NF-kappa B; Platelet Activating Factor; Platelet Count; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor Receptor-Associated Peptides and Proteins; Young Adult | 2016 |